Treatment of rosacea using radiofrequency microneedling
Official title: Split-Face Comparison of 532nm Potassium Titanyl Phosphate (KTP) Laser Treatment Versus Radiofrequency Microneedling in Combination With 532 KTP Laser for Erythematotelangiectatic or Papulopustular Rosacea
Run by University of Miami · NCT06801717 · Data updated 2026-11-12
This study is testing if using radiofrequency microneedling, alone or with a special laser, can help adults with rosacea feel better and improve their skin.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Miami Academic / other |
| Locations | 1 site (Miami Beach, Florida) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT06801717 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with a clinical diagnosis of erythematotelangiectatic or papulopustular rosacea.
✕Probably not a fit
Patients currently using oxymetazoline or brimonidine, or those with certain skin conditions or sensitivities, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of radiofrequency microneedling for treating erythematotelangiectatic and papulopustular rosacea. It will also explore the potential benefits of combining this treatment with the 532 nm KTP laser. The study will involve adult participants who meet specific health criteria and will assess both clinical outcomes and novel therapeutic strategies for rosacea management.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the management of rosacea symptoms for affected patients.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in using microneedling techniques for various skin conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female adult (\>18yo) subjects in general good health 2. Clinical and/or histologic diagnosis of erythematotelangiectatic or papulopustular rosacea. 3. Subject is able to understand and sign informed consent 4. Subject is able to complete the study and comply with study procedures Exclusion Criteria: 1. Patients currently utilizing oxymetazoline or brimonidine. 2. Presence of dermatoses that might interfere with diagnosis as determined by a study investigator 3. Presence of extreme light sensitivity, or conditions pre-disposing to light sensitivity such as but not limited to xeroderma pigmentosum 4. Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment 5. History of poor wound healing or blood-clotting abnormality 6. History of keloid formation or hypertrophic scarring 7. Hypersensitivity or contraindication to local anesthetics as determined by the principal investigator or other medical professional. 8. Prisoners
Where it's running
-
University of Miami Dermatology Miami Beach Clinic
Miami Beach, Florida, United States Recruiting
Study contacts
- Principal investigator: Ariel Eber, MD — University of Miami
- Study coordinator: Maria Muniz Muniz
- Email: mmuniz@med.miami.edu
- Phone: 305-689-2646
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous Auricular Vagus Nerve Stimulation for Rosacea
A small, single-arm pilot study will test whether taVNS can help adults with rosacea and moderate flushing or redness.
-
Dermocosmetic treatment for facial redness in rosacea with or without laser therapy
A dermocosmetic product is tested to see if it reduces facial redness and visible blood vessels in adults with erythematotelangiectatic rosacea, on one side of the face compared to placebo, alone and with laser therapy.
-
Neural links for real-world emotions in mood and anxiety
Researchers are testing how real-life emotional moments relate to brain activity and stress responses in young adults with mood and anxiety symptoms, using smartphones, self-reports, tasks, and MRI.
-
Lixumistat window of opportunity in newly diagnosed glioblastoma
This study tests whether Lixumistat can benefit adults with newly diagnosed glioblastoma who are planned for surgical tumor removal.
-
Velocity-Loss Resistance Training in Parkinson's Disease
This trial tests whether two velocity-loss resistance training thresholds (10% vs 30%) improve muscle strength, power, and daily function in older adults with Parkinson's disease.
-
Noninvasive ear stimulation for HIV-related nerve pain
This study tests a non-invasive ear stimulation device to see if it can help nerve pain in people with HIV who have HIV-associated peripheral neuropathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.